It has been a privilege for Recobia Therapeutics to join the MATWIN’s #Meet2Win event in Bordeaux on May 6th and 7th…and win the 1st Prize of the quick pitch award !
This not to be missed convention bringing more than 300 experts from researchers, clinicians, start-ups, manufacturers, investors and patients associations has once again demonstrated its major impact to progress therapies against cancer.
Whilst disclosing the results of our preclinical campaign this was a great opportunity to demonstrate our technology’s robustness, versatility, biocompatibility, degradability, superior release profile and therapeutic effect.
Building on top of these promising results, Vincent Gass has restated the strong and differentiating value proposition of translating intravenous administration to subcutaneous, now made possible for antibodies and their conjugates.
See more info: https://www.linkedin.com/feed/update/urn:li:activity:7328720029573595136